BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting women of reproductive age. Its clinical expression is diverse, including metabolic, behavioral, and reproductive effects, with many affected by obesity and decreased quality of life. Women with PCOS who have undergone surgically induced weight loss have reported tremendous benefit, not only with weight loss, but also improvement of hyperandrogenism and menstrual cyclicity. METHODS: In a rat model of PCOS achieved via chronic administration of dihydrotestosterone (DHT) exposure, we investigated the ability of bariatric surgery, specifically vertical sleeve gastrectomy (VSG), to ameliorate the metabolic, behavioral, and reproductive abnormalities invoked by this PCOS model. RESULTS: We found that DHT treatment combined with exposure to a high-fat diet resulted in increased body weight and body fat, impaired fasting glucose, hirsutism, anxiety, and irregular cycles. VSG resulted in reduced food intake, body weight, and adiposity with improved fasting glucose and triglycerides. VSG induced lower basal corticosterone levels and attenuated stress responsivity. Once the DHT levels decreased to normal, regular estrous cyclicity was also restored. CONCLUSIONS: VSG, therefore, improved PCOS manifestations in a comprehensive manner and may represent a potential therapeutic approach for specific aspects of PCOS.
BACKGROUND:Polycystic ovary syndrome (PCOS) is the most common endocrinopathy affecting women of reproductive age. Its clinical expression is diverse, including metabolic, behavioral, and reproductive effects, with many affected by obesity and decreased quality of life. Women with PCOS who have undergone surgically induced weight loss have reported tremendous benefit, not only with weight loss, but also improvement of hyperandrogenism and menstrual cyclicity. METHODS: In a rat model of PCOS achieved via chronic administration of dihydrotestosterone (DHT) exposure, we investigated the ability of bariatric surgery, specifically vertical sleeve gastrectomy (VSG), to ameliorate the metabolic, behavioral, and reproductive abnormalities invoked by this PCOS model. RESULTS: We found that DHT treatment combined with exposure to a high-fat diet resulted in increased body weight and body fat, impaired fasting glucose, hirsutism, anxiety, and irregular cycles. VSG resulted in reduced food intake, body weight, and adiposity with improved fasting glucose and triglycerides. VSG induced lower basal corticosterone levels and attenuated stress responsivity. Once the DHT levels decreased to normal, regular estrous cyclicity was also restored. CONCLUSIONS: VSG, therefore, improved PCOS manifestations in a comprehensive manner and may represent a potential therapeutic approach for specific aspects of PCOS.
Authors: Eliana H Akamine; Anderson C Marçal; João Paulo Camporez; Mara S Hoshida; Luciana C Caperuto; Estela Bevilacqua; Carla R O Carvalho Journal: J Endocrinol Date: 2010-05-07 Impact factor: 4.286
Authors: S Benson; P C Arck; S Tan; S Hahn; K Mann; N Rifaie; O E Janssen; M Schedlowski; S Elsenbruch Journal: Psychoneuroendocrinology Date: 2009-01-15 Impact factor: 4.905
Authors: Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart Journal: Fertil Steril Date: 2011-12-06 Impact factor: 7.329
Authors: Ilana B Ressler; Bernadette E Grayson; Yvonne M Ulrich-Lai; Randy J Seeley Journal: Am J Physiol Endocrinol Metab Date: 2015-04-14 Impact factor: 4.310
Authors: Joshua Dilday; Michael Derickson; John Kuckelman; Cara Reitz; Eric Ahnfeldt; Matthew Martin; J Paul Sanders Journal: Obes Surg Date: 2019-01 Impact factor: 4.129
Authors: William J Lawson; Kristin Shirey; Redin A Spann; Carlos A Zamarripa; Jonathan P Hosler; Bernadette E Grayson Journal: Menopause Date: 2017-04 Impact factor: 2.953